(Q27478096)

2

0 references

W L Rill

3

0 references

G M Swartz

4

0 references

P G Canonico

Antimicrobial Agents and Chemotherapy

5

0 references

language of work or name

English

0 references

publication date

June 1985

0 references

published in

0 references

volume

27

0 references

issue

6

0 references

page(s)

903-7

0 references

cites work

Rift Valley Fever virus in mice. I. General features of the infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180183

Plasma disappearance, urine excretion, and tissue distribution of ribavirin in rats and rhesus monkeys

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180183

The extended horizons of Rift Valley fever: current and projected immunogens.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180183

Efficacy of liposome-intercalated amphotericin B in the treatment of systemic candidiasis in mice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180183

Delivery of liposome-encapsulated drugs to macrophages

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180183

Protective effect of a muramyl dipeptide analog encapsulated in or mixed with liposomes against Candida albicans infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180183

29 September 2017

New aspects of liposomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180183

The Rift Valley fever epizootic in Egypt 1977–1978 1. Description of the epizootic and virological studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180183

Therapy of leishmaniasis: Superior efficacies of liposome-encapsulated drugs

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180183

Treatment of experimental visceral leishmaniasis with lymphokine encapsulated in liposomes.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180183

Liposome-encapsulated cephalothin in the treatment of experimental murine salmonellosis

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180183

27 November 2018

1 reference

12 December 2020

Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B

1 reference

PubMed

12 December 2020

Treatment of murine cryptococcosis with liposome-associated amphotericin B

1 reference

PubMed

12 December 2020

Antileishmanial activity of amphotericin and other antifungal agents entrapped in liposomes

1 reference

PubMed

12 December 2020